1 / 11

Aarkstore - Epstein-Barr Viral Infections - Pipeline Review,

“Epstein-Barr Viral Infections - Pipeline Review, H2 2014”, provides an overview of the Epstein-Barr Viral Infectionss therapeutic pipeline. For more details : http://goo.gl/OSVbxS

Shubhangi
Download Presentation

Aarkstore - Epstein-Barr Viral Infections - Pipeline Review,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014 www.aarkstore.com

  2. Summary “Epstein-Barr Viral Infections - Pipeline Review, H2 2014”, provides an overview of the Epstein-Barr Viral Infectionss therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Epstein-Barr Viral Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epstein-Barr Viral Infections and special features on late-stage and discontinued projects. www.aarkstore.com www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Epstein-Barr Viral Infections- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Epstein-Barr Viral Infections and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Epstein-Barr Viral Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Epstein-Barr Viral Infections pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products www.aarkstore.com www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Epstein-Barr Viral Infections- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Epstein-Barr Viral Infections pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com www.aarkstore.com

  5. Table of Contents Introduction 6Global Markets Direct Report Coverage 6Epstein-Barr Viral Infections Overview 7Therapeutics Development 8Pipeline Products for Epstein-Barr Viral Infections - Overview 8Pipeline Products for Epstein-Barr Viral Infections - Comparative Analysis 9Epstein-Barr Viral Infections - Therapeutics under Development by Companies 10Epstein-Barr Viral Infections - Therapeutics under Investigation by Universities/Institutes 11Epstein-Barr Viral Infections - Pipeline Products Glance 13Clinical Stage Products 13Early Stage Products 14Epstein-Barr Viral Infections - Products under Development by Companies 15Epstein-Barr Viral Infections - Products under Investigation by Universities/Institutes 16 www.aarkstore.com www.aarkstore.com

  6. List Of Tables Number of Products under Development for Epstein-Barr Viral Infections, H2 2014 8Number of Products under Development for Epstein-Barr Viral Infections - Comparative Analysis, H2 2014 9Number of Products under Development by Companies, H2 2014 10Number of Products under Investigation by Universities/Institutes, H2 2014 12Comparative Analysis by Clinical Stage Development, H2 2014 13Comparative Analysis by Early Stage Development, H2 2014 14Products under Development by Companies, H2 2014 15Products under Investigation by Universities/Institutes, H2 2014 16Epstein-Barr Viral Infections - Pipeline by Cell Medica Limited, H2 2014 17Epstein-Barr Viral Infections - Pipeline by Conkwest, Inc., H2 2014 18 www.aarkstore.com

  7. List Of Figures Number of Products under Development for Epstein-Barr Viral Infections, H2 2014Number of Products under Development for Epstein-Barr Viral Infections - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014 Number of Products under Investigation by Universities/Institutes, H2 2014 Comparative Analysis by Clinical Stage Development, H2 2014 Comparative Analysis by Early Stage Products, H2 2014 Assessment by Monotherapy Products, H2 2014 Number of Products by Top 10 Targets, H2 2014 Number of Products by Stage and Top 10 Targets, H2 2014 Number of Products by Top 10 Mechanism of Actions, H2 2014 www.aarkstore.com

  8. Related Market Research reports: • Blirt S.A. - Product Pipeline Review – 2014 • Auris Medical Holding AG - Product Pipeline Review – 2014 • Integral Molecular, Inc. - Product Pipeline Review – 2014 • DaVinci Biosciences, LLC - Product Pipeline Review – 2014 • Actavis plc - Product Pipeline Review - 2014 www.aarkstore.com

  9. Related Market Research reports: • TiGenix NV - Product Pipeline Review – 2014 • Egenix, Inc. - Product Pipeline Review – 2014 • SkyePharma PLC - Product Pipeline Review – 2014 • MediWound Ltd. - Product Pipeline Review – 2014 • BioTech Tools s.a. - Product Pipeline Review - 2014 www.aarkstore.com

  10. Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014 www.aarkstore.com

  11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com

More Related